NovoPath Announces the Addition of the NovoPath™ Dashboard
News Jul 16, 2015
NovoPath, Inc. has announced the addition of the NovoPath™ Dashboard to its NovoPath™ Anatomic Pathology Software Platform. The Dashboard provides lab managers a quick and reliable, at-a-glance view of operational data, enabling them to monitor progress, anticipate bottlenecks and avoid potential problems throughout the lab.
"Having the ability to monitor operational efficiency in real -time is crucial to a lab's success in today's time-pressed anatomic pathology environment," notes Rick Callahan, vice president of sales and marketing for NovoPath. "Typically, labs deal with problems after they negatively impact efficiency. With the NovoPath Dashboard, the lab manager can proactively monitor the pulse of the lab and make needed adjustments to eliminate bottlenecks and maximize efficiency."
Callahan points out that critical statistical information is available in an easy-to-read, graph or chart format for a quick visual overview. "NovoPath is designed based on a deep understanding of anatomic pathology workflow and offers a broad range of flexible features that help pathologists and labs function efficiently," adds Callahan.
He notes that the deployment of modules such as the NovoPath Dashboard will help in positioning a lab to succeed in the ever-changing laboratory environment.
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.
Machine Learning Helps Predict Schizophrenia Treatment OutcomesNews
New research that used a machine-learning algorithm to investigate MRI images of schizophrenia patients has successfully identified response to antipsychotic treatment in 4 out of 5 patients.READ MORE
Big Data Analysis Identifies New Cancer Risk GenesNews
Researchers at the Centre for Genomic Regulation (CRG) in Barcelona have developed a new method to systematically identify genes contributing to heritable cancer risk. Their work, which is published in Nature Communications, is a success story for data sharing and openness in science. A small team of three researchers identified new cancer genes only using publicly available data.READ MORE